Clinical Trials Browser

Rectal Neoplasms × balstilimab × 90 days × Clear all

NCT07227636 2026-02-06

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms